In this role, you will define and execute agreed sales strategies within a given geographic territory. You will focus on pharmaceutical pre-clinical and clinical research, hospitals, clinical diagnostics, and related healthcare professions. For each subvertical, you will identify business potential and build long term business relationships with key decision makers in order to expand our current client base in your assigned territory. In order to be successful in this role, we expect you to be able to rapidly apply medical and scientific information pertaining to clinical diagnostics. Moreover, you will have experience in presenting in front of groups of professionals at CSO/CEO level.
On a day-to-day basis, you will:
We are looking for people who have:
ABOUT NEOTERYX
Neoteryx is a brand of Trajan Scientific and Medical, providing scientifically precise remote specimen collection and microsampling technologies. To support Trajan’s vision of enabling science that benefits people and improves wellbeing, Neoteryx innovates and develops quantitative microsampling technologies that are easy to use and amenable to manual and automated analysis in the lab. Neoteryx microsampling technologies ease workflows and enable decentralized research and healthcare models. Our product portfolio includes the Mitra® device based on VAMS® technology, the hemaPEN® that advances both capillary and DBS technologies, and more microsampling products on the way.
Watch this video to learn more!
Department: Commercial
Reports to: Business Development Director
Status: 100% (40h/week)
Salary: Competitive, Depending on Experience
Location: Germany
Benefits: Offered for Regular Full Time Employees
Travel: 25% of the time
Contact Us
Trajan Scientific Americas Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine.
In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group.
Copyright © 2022. All rights reserved.